Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director comp.
Appointed director
Appointed CFO
Director departure
Inv. presentation
Quarterly results
Consulting agrmnt
Alliqua BioMedical, Inc. (ADYX) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/20/2020 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
03/20/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/20/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/20/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/20/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/20/2020 RW Form RW - Registration Withdrawal Request:
12/17/2019 8-K Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Form of convertible promissory note issued to entities affiliated with Domain Associates LLC in December 2019"
11/14/2019 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
11/14/2019 10-Q Quarterly Report for the period ended September 30, 2019
11/14/2019 8-K Quarterly results
11/14/2019 10-Q/A Quarterly Report for the period ended June 30, 2019 [amend]
11/08/2019 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
10/11/2019 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
10/02/2019 8-K Quarterly results
08/22/2019 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
08/14/2019 10-Q Quarterly Report for the period ended June 30, 2019
08/14/2019 8-K Quarterly results
Docs: "Adynxx, Inc. Condensed Consolidated Statements of Operations Three months ended June 30, Six months ended June 30, 2019 2018 2019 2018 Operating expenses Research and development $ 1,895 $ 583 $ 3,226 $ 1,269 General and administrative 1,454 598 2,317 1,292 Grant reimbursements - - Total operating expenses, net 2,245 1,181 4,345 2,561 Loss from operations Interest expense, net Other income , net - 60 60 Loss from continuing operations Loss from discontinued operations - - Net loss $ $ $ $ Net loss per basic and diluted share: Loss from continuing operations $ $ $ $ Loss from discontinued operations - - Net loss per basic and diluted share $ $ $ $ Weighted-average number of common shares outstanding - basic and diluted 5,358,882 4,569,742 4,966,491 4,569,742 Adynxx, Inc. Condensed Co..."
08/13/2019 DEF 14C Form DEF 14C - Other definitive information statements:
08/02/2019 PRE 14C Form PRE 14C - Other preliminary information statements:
08/01/2019 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sales of Eq...
08/01/2019 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
07/24/2019 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
07/22/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/26/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Shareholder Letter, issued on June 26, 2019"
06/17/2019 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
06/17/2019 8-K Termination of a Material Definitive Agreement
06/12/2019 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
06/10/2019 8-K/A Financial Statements and Exhibits  Interactive Data
Docs: "Consent of BDO USA, LLP, Private Adynxx’s independent registered public accounting firm",
"Audited financial statements of Private Adynxx as of and for the years ended December 31, 2018 and 2017 and unaudited financial statements of Private Adynxx for the three months ended March 31, 2019 and 2018",
"Unaudited pro forma condensed combined balance sheet as of March 31, 2019 and unaudited combined condensed statement of operations for the year ended December 31, 2018 and the three months ended March 31, 2019"
05/31/2019 8-K Changes in Registrant's Certifying Accountant, Departure of Directors or Certain Officers; Election of Directors; Appointment...
Docs: "Letter from Marcum LLP to the Securities and Exchange Commission"
05/14/2019 SC 13D/A TPG Group Holdings Advisors, Inc. reports a 18.9% stake in Adynxx, Inc.
05/13/2019 SC 13D Domain Partners VIII, L.P. reports a 52.3% stake in Adynxx, Inc.
05/10/2019 GN Adynxx Announces Payment Date of Special Cash Dividend Previously Announced by Alliqua BioMedical
05/09/2019 8-K Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation or an Obligation under an Off-B...
Docs: "Certificate of Amendment to Certificate of Incorporation to Effect the Name Change",
"Certificate of Amendment to Certificate of Incorporation to Effect the Reverse Stock Split",
"Form of Common Stock Certificate",
"Loan and Security Agreement, and as amended from time to time, by and among Adynxx, Inc. and Oxford Finance LLC",
"Form of promissory note issued to Oxford Finance LLC",
"Form of warrant issued to Oxford Finance LLC",
"Offer Letter, by and between Rick Orr and Adynxx, Inc",
"Offer Letter, by and between Donald Manning, M.D., Ph.D., and Adynxx, Inc",
"Offer Letter, by and between Julien Mamet, Ph.D. and Adynxx, Inc",
"Adynxx, Inc. 2010 Equity Incentive Plan Adopted by the Board of Directors: December 8, 2010 Approved by the Stockholders: December 8, 2010 Termination Date: December 7, 2020 1. General. Eligible Stock Award Recipients. The persons eligible to receive Stock Awards are Employees, Directors and Consultants. Available Stock Awards. The Plan provides for the grant of the following Stock Awards: Incentive Stock Options, Nonstatutory Stock Options, Stock Appreciation Rights, Restricted Stock Awards, and Restricted Stock Unit Awards. Purpose. The Company, by means of the Plan, seeks to secure and retain the services of the group of persons eligible to receive Stock Awards as set forth in Section 1, to provide incentives for such persons to exert maximum efforts for the success of the Company and a..."
05/06/2019 GN Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre Legault and Matt Ruth to Board of Directors
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy